Therapeutic immune response induced by electrofusion of dendritic and tumor cells (Q40651689)

22 September 2017

Therapeutic immune response induced by electrofusion of dendritic and tumor cells (English)

1 reference

22 September 2017

Hiroshi Tanaka

1

1 reference

22 September 2017

Keiji Shimizu

series ordinal

2

1 reference

22 September 2017

Takashi Hayashi

series ordinal

3

1 reference

22 September 2017

Suyu Shu

series ordinal

4

1 reference

22 September 2017

1 November 2002

1 reference

22 September 2017

1 reference

22 September 2017

220

1 reference

22 September 2017

1-12

1 reference

22 September 2017

1

1 reference

Dendritic cells and the control of immunity

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Active immunization against cancer with dendritic cells: the near future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Induction of protective anti-tumor immunity by gene-modified dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

RNA-transfected dendritic cells in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Electric field-induced cell-to-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Electrofusion of cells: hybridoma production by electrofusion and polyethylene glycol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Principles of electrofusion and electropermeabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Reciprocal control of T helper cell and dendritic cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Therapeutic efficacy of Th1 and Th2 L-selectin--CD4+ tumor-reactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Membrane electrofusion: a paradigm for study of membrane fusion mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Developmental regulation of MHC class II transport in mouse dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Transport of peptide-MHC class II complexes in developing dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900009-1

10.1016/S0008-8749(03)00009-1

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference